Michael Haddadin (@joleukemologist) 's Twitter Profile
Michael Haddadin

@joleukemologist

Hem/Onc l Focus:🩸Myeloid Neoplasm Enthusiast🩸- MPN MDS AML & Allo-SCT I Hob: 🎹 🎬 🎥 ⛰I #JUST🇯🇴#KHCC #SUNY #MSKCC #UMass Chief Res & Fellow #ManUtd #EPL

ID: 1499261765653311488

calendar_today03-03-2022 05:54:33

13 Tweet

72 Followers

215 Following

Michael Haddadin (@joleukemologist) 's Twitter Profile Photo

Great Work by Dr. Amer Zeidan MBBS,MHS ‏عامر زيدان & The myeloid Consortium. It is truly an urging need now, for such a change. Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes ashpublications.org/blood/article-… #mdssm #mds2023

Michael Haddadin (@joleukemologist) 's Twitter Profile Photo

Excited to speak and be part of this incredible conference! Grateful to Dr. Binay Shah, MD, MHA & the organizers Krishna Gundabolu MBBS; MS & Christopher D'Angelo for the invite—what an inspiring mission behind this foundation Binaytara Kicking off with a power-packed malignant heme update and rich

Michael Haddadin (@joleukemologist) 's Twitter Profile Photo

🔬Precision medicine isn’t about doing more — it’s about doing right! Not every remission is a victory. 🧓🧓 Geriatric assessment helps us hit that mark 🎯 Inspired by Vijaya R Bhatt, MBBS, MS at the Fred & Pamela Buffett Cancer Center University of Nebraska Medical Center doi.org/10.1002/ajh.27… #leumsm #gerionc

VJHemOnc (@vjhemonc) 's Twitter Profile Photo

#ASCO25 | Julie Vose just outlined how and when to use epcoritamab in patients with relapsed or refractory follicular lymphoma. ASCO #LYMsm #NonHodgkinLymphoma #ImmunoOnc

#ASCO25 | <a href="/DrJulieVose/">Julie Vose</a> just outlined how and when to use epcoritamab in patients with relapsed or refractory follicular lymphoma.

<a href="/ASCO/">ASCO</a> #LYMsm #NonHodgkinLymphoma #ImmunoOnc
Michael Haddadin (@joleukemologist) 's Twitter Profile Photo

🌊 Hang ten, heme fam! #2025PPLC -is officially riding the wave! 🏄‍♂️🏄‍♀️ Massive mahalo to all our epic speakers, trailblazing sponsors, and the leukemia ohana for making this collab at Honolua Bay 🌺🤙 Huge shout-out to the organizing committee for steering this surfboard. #Lmsm

🌊 Hang ten, heme fam!
#2025PPLC -is officially riding the wave! 🏄‍♂️🏄‍♀️

Massive mahalo to all our epic speakers, trailblazing sponsors, and the leukemia ohana for making this collab at Honolua Bay 🌺🤙

Huge shout-out to the organizing committee for steering this surfboard. #Lmsm
Michael Haddadin (@joleukemologist) 's Twitter Profile Photo

💥 Let’s talk B-ALL! 💬🧠 Our expert panel just crushed it discussing some 🔥 topics: #2025PPLC #Leusm #ALLIn 🩸✨💥 👦 Importance of Pediatric-inspired regimens in adults 👶 🚗🎯CAR-T: tackling resistance & redefining its role in the modern playbook 🧠 CNS disease in ALL!

💥 Let’s talk B-ALL! 💬🧠
Our expert panel just crushed it discussing some 🔥 topics: #2025PPLC #Leusm #ALLIn 🩸✨💥

👦 Importance of Pediatric-inspired regimens in adults 👶
🚗🎯CAR-T: tackling resistance &amp; redefining its role in the modern playbook
🧠 CNS disease in ALL!
Michael Haddadin (@joleukemologist) 's Twitter Profile Photo

🔎 A fully loaded #PPLC2025 session on all things #myelofibrosis & #mpnsm Mahalo for the insight ! & clinical nuggets of Drs. Naveen Pemmaraju, MD, Ruben A. Mesa, MD, Laura C. Michaelis, Toyosi Odenike - for walking us through 🔄 evolving strategies in disease modification—from combos ➕ to immune

🔎 A fully loaded #PPLC2025 session on all things #myelofibrosis &amp; #mpnsm 
Mahalo for the insight ! &amp; clinical nuggets of Drs. <a href="/doctorpemm/">Naveen Pemmaraju, MD</a>, <a href="/mpdrc/">Ruben A. Mesa, MD</a>, <a href="/lauracmichaelis/">Laura C. Michaelis</a>, <a href="/myeloidmalig/">Toyosi Odenike</a>  - for walking us through 🔄 evolving strategies in disease modification—from combos ➕ to immune